Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2016 06:30 ET | Source: Radius Health Inc.

Radius Health Reports First Quarter 2016 Financial and Operating Results

Radius submitted an NDA to the US FDA for abaloparatide-SC for the treatment of postmenopausal women with osteoporosis and reduction of fracture risk. An MAA for abaloparatide-SC is currently...
May 02, 2016 11:45 ET | Source: Radius Health Inc.

Radius Health to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

WALTHAM, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis,...
April 21, 2016 13:17 ET | Source: Radius Health Inc.

Radius Health to Present at the Deutsche Bank 41st Annual Health Care Conference

WALTHAM, Mass., April 21, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company committed to developing innovative therapeutics in the areas of...
April 15, 2016 15:37 ET | Source: Radius Health Inc.

Radius Announces Three Oral Presentations for Abaloparatide-SC at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Disease

-Highlights from Phase 3 ACTIVE and ACTIVExtend Trials--New Results from WHO FRAX® assessment of ACTIVE Trial demonstrate consistency of fracture risk reduction--WCO-IOF-ESCEO Malaga 2016 is the...
April 12, 2016 07:00 ET | Source: Radius Health Inc.

Radius Health to Announce First Quarter 2016 Financial Results, Host Conference Call and Live Webcast on May 5, 2016

WALTHAM, Mass., April 12, 2016 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its first quarter 2016 financial results on Thursday, May 5, 2016. In...
April 01, 2016 16:30 ET | Source: Radius Health Inc.

Radius Health Announces New Employment Inducement Grants

WALTHAM, Mass., April 01, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company committed to developing innovative therapeutics in the areas of...
April 01, 2016 12:00 ET | Source: Radius Health Inc.

Radius Presents Analysis Results on Fracture Risk Reduction in Phase 3 ACTIVE Trial for Investigational Drug Abaloparatide-SC at the ENDO 2016 Annual Meeting

WALTHAM, Mass., April 01, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company committed to developing innovative therapeutics in the areas of...
March 30, 2016 15:17 ET | Source: Radius Health Inc.

Radius Health Submits New Drug Application to the U.S. Food and Drug Administration for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis

– Significant Reduction in the Risk of Vertebral, Nonvertebral, Clinical and Major Osteoporotic Fractures and Increases in Bone Mineral Density in Phase 3 Studies – – If approved,...
March 11, 2016 16:01 ET | Source: Radius Health Inc.

Radius Health Announces New Employment Inducement Grants

WALTHAM, Mass., March 11, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with...
February 29, 2016 14:01 ET | Source: Radius Health Inc.

Radius Health to Present at the Cowen and Company 36th Annual Health Care Conference

WALTHAM, Mass., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with...